FDA Clinical Trial Oversight: Agency Must Ensure “System Is Not Broken”

FDA needs to demonstrate to the public that the "clinical trial system is not broken," Associate Commissioner Murray Lumpkin, MD, told the American Association of Pharmaceutical Scientists' annual meeting in Toronto Nov. 11